Device Trial Radar · NCT00692276
Investigating Superion™ In Spinal Stenosis
Last checked: Nov 20, 2026Latest source record: Nov 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
391
Actual
Start
Jun 2008
Primary completion
Feb 2017
Study completion Feb 2017
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- Collaborators
- VertiFlex, Incorporated
- First posted
- Jun 6, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The proposed prospective, multi-center, randomized clinical trial is designed to evaluate the safety and effectiveness of the Superion™ ISS compared to the X-STOP® IPD® device in healthy adults suffering from at least 6 months of moderate spinal stenosis symptoms who have been unresponsive to conservative care.
Conditions
- Lumbar Spinal Stenosis
- Intermittent Claudication
Interventions
Superion™ Interspinous SpacerDevice
Implantation of interspinous process spacer to treat lumbar spinal stenosis
X-STOP® IPD® DeviceDevice
Implantation of interspinous process spacer to treat lumbar spinal stenosis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With Clinically Significant Improvement in OutcomesTime frame: Baseline and 24 months
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Arizona Center for Neurosurgery
Phoenix, Arizona
Tucson Orthopaedic Institute
Tucson, Arizona
D.I.S.C. Sports and Spine Center
Beverly Hills, California
29 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.